Hostname: page-component-cd9895bd7-jkksz Total loading time: 0 Render date: 2024-12-27T06:09:12.791Z Has data issue: false hasContentIssue false

Massive levothyroxine ingestion in a pediatric patient: case report and discussion

Published online by Cambridge University Press:  11 May 2015

Josephine Ho*
Affiliation:
Faculty of Medicine, University of Calgary, Calgary, AB
Renee Jackson
Affiliation:
Division of Pediatrics, Alberta Children's Hospital, Calgary, AB
David Johnson
Affiliation:
Faculty of Medicine, University of Calgary, Calgary, AB
*
Division of Pediatric Endocrinology, Alberta Children's Hospital, 2888 Shaganappi Trail NW, Calgary, AB T3B 6A8; josephine.ho@albertahealthservices.ca.

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

We describe the course of a toddler who ingested a massive amount of levothyroxine and review treatment options for such overdoses. A 2½-year-old boy presented shortly after an ingestion of up to 7.6 mg of levothyroxine (potentially as much as 700 µg/kg). He was initially asymptomatic, treated with oral charcoal 1 g/kg, and discharged home from the emergency department after a few hours. He returned approximately 24 hours later with a temperature of 38.5°C, heart rate of 163 beats per minute, respiratory rate of 30 breaths per minute, and blood pressure of 136/70 mm Hg. He had a slightly decreased appetite and no signs or symptoms of infection. He was admitted to hospital and treated with oral acetaminophen. The initial free thyroxine (T4) was > 100 pmol/L and free triiodothyronine (T3) was 35.3 pmol/L. The patient had desquamation of the palms and soles, hair loss, and irritability during the month following the ingestion. Resolution of the elevated free T4 occurred by 12 days post-ingestion and normalization of the thyroid-stimulating hormone by 7 weeks post-ingestion. There were no longterm sequelae. Levothyroxine overdose can result in significant complications, including seizures and arrhythmias, both of which should be monitored for. However, as our case illustrates, massive ingestion of levothyroxine in children typically follows a benign course.

Type
Case Report • Rapport de cas
Copyright
Copyright © Canadian Association of Emergency Physicians 2011

References

REFERENCES

1.Canaris, GJ, Manowitz, NR, Mayor, G, et al. The Colorado thyroid disease prevalence study. Arch Intern Med 2000;160:526–34, doi:10.1001/archinte.160.4.526.CrossRefGoogle ScholarPubMed
2.Pediatric Lexi-Drugs ONLINE. Hudson (OH): American Pharmaceutical Association; 2010.Google Scholar
3.Bronstein, AC, Spyker, DA, Cantilena, LR Jr, et al. 2008 annual report of the American Association of Poison Control Centers’ National Poison Data System (NPDS): 26th annual report. Clin Toxicol (Phila) 2009;47:9111084, doi:10.3109/15563650903438566.CrossRefGoogle Scholar
4.Gorman, RL, Chamberlain, JM, Rose, SR, et al. Massive levothyroxine overdose: high anxiety–low toxicity. Pediatrics 1988;82:666–9.CrossRefGoogle ScholarPubMed
5.Lewander, WJ, Lacouture, PG, Silva, JE, et al. Acute thyroxine ingestion in pediatric patients. Pediatrics 1989;84:262–5.Google Scholar
6.Willgerodt, H, Keller, E, Sorger, D, et al. Acute ingestion of thyroxine and triiodothyronine in young children. Eur J Pediatr 2003;162:639–41, doi:10.1007/s00431-003-1263-2.Google Scholar
7.Lehrner, LM, Weir, MR. Acute ingestions of thyroid hormones. Pediatrics 1984;73:313–7.Google Scholar
8.Roesch, C, Becker, PG, Sklar, S. Management of a child with acute thyroxine ingestion. Ann Emerg Med 1985;14:1114–5, doi:10.1016/S0196-0644(85)80935-5.CrossRefGoogle ScholarPubMed
9.Berkner, PD, Starkman, H, Person, N. Acute L-thyroxine overdose; therapy with sodium ipodate: evaluation of clinical and physiologic parameters. J Emerg Med 1991;9:129–31, doi:10.1016/0736-4679(91)90317-9.CrossRefGoogle ScholarPubMed
10.Litovitz, TL, White, JD. Levothyroxine ingestions in children: an analysis of 78 cases. Am J Emerg Med 1985;3:297300, doi:10.1016/0735-6757(85)90050-6.CrossRefGoogle ScholarPubMed
11.Tenenbein, M, Dean, HJ. Benign course after massive levothyroxine ingestion. Pediatr Emerg Care 1986;2:15–7, doi:10.1097/00006565-198603000-00004.CrossRefGoogle ScholarPubMed
12.Tsutaoka, BT, Kim, S, Santucci, S. Seizure in a child after an acute ingestion of levothyroxine. Pediatr Emerg Care 2005;21:857–9, doi:10.1097/01.pec.0000190240.81222.9a.CrossRefGoogle Scholar
13.Shilo, L, Kovatz, S, Hadari, R, et al. Massive thyroid hormone overdose: kinetics, clinical manifestations and management. Isr Med Assoc J 2002;4:298–9.Google Scholar
14.Matthews, SJ. Acute thyroxine overdosage: two cases of parasuicide. Ulster Med J 1993;62:170–3.Google ScholarPubMed
15.Kulig, K, Golightly, LK, Rumack, BH. Levothyroxine overdose associated with seizures in a young child. JAMA 1985;254:2109–10, doi:10.1001/jama.254.15.2109.Google Scholar
16.Binimelis, J, Bassas, L, Marruecos, L, et al. Massive thyroxine intoxication: evaluation of plasma extraction. Intensive Care Med 1987;13:33–8, doi:10.1007/BF00263555.CrossRefGoogle ScholarPubMed
17.Ioos, V, Das, V, Maury, E, et al. A thyrotoxicosis outbreak due to dietary pills in Paris. Ther Clin Risk Manag 2008;4:1375–9.Google Scholar
18.Tunget, CL, Clark, RF, Turchen, SG, et al. Raising the decontamination level for thyroid hormone ingestions. Am J Emerg Med 1995;13:913, doi:10.1016/0735-6757(95)90231-7.CrossRefGoogle ScholarPubMed
19.Chyka, PA, Seger, D, Krenzelok, EP, et al. Position paper: single-dose activated charcoal. Clin Toxicol (Phila) 2005;43:6187.Google Scholar
20.Vale, JA, Kulig, K. Position paper: gastric lavage. J Toxicol Clin Toxicol 2004;42:933–43, doi:10.1081/CLT-200045006.Google ScholarPubMed
21.Kreisner, E, Lutzky, M, Gross, JL. Charcoal hemoperfusion in the treatment of levothyroxine intoxication. Thyroid 2010;20:209–12, doi:10.1089/thy.2009.0054.Google Scholar